Author Archives: Deal With Cancer Team

Anticancer Property of VR23 Proteasome Inhibitor

The proteasome is clinically validated as a target for cancer therapeutics. However, proteasome-inhibitory agents that are cancer selective have yet to be developed. In this study, we report the identification of a safe and effective proteasome inhibit...

Mathematical Model of Bladder Tumorigenesis

Relationships between genetic alterations, such as co-occurrence or mutual exclusivity, are often observed in cancer, where their understanding may provide new insights into etiology and clinical management. In this study, we combined statistical analy...